A growing body of research is reshaping how scientists understand the earliest moments of life, with new findings showing that fragments of ancient viruses embedded in our genomes play a surprisingly active role in embryonic development. Studies published over the past year reveal that endogenous retroviruses (ERVs) — once dismissed as “junk DNA” — help orchestrate the cellular reprogramming that transforms a fertilised egg into a fully developed organism. The discoveries, drawn from work in mammalian embryos and stem cells, are forcing evolutionary biologists to reconsider how viruses have shaped multicellular life over hundreds of millions of years.
From Genetic Parasites to Developmental Architects
Endogenous retroviruses are remnants of viral infections that occurred in our ancestors and became permanently integrated into the germline. Roughly 8% of the human genome consists of such sequences — far more than the approximately 2% that codes for proteins. For decades, these stretches of DNA were considered evolutionary detritus, silenced by the cell to prevent harm. But evidence assembled by researchers at institutions including the Centre for Genomic Regulation in Barcelona and collaborators across Europe now demonstrates that some ERVs are not merely tolerated but are actively recruited at specific moments of embryogenesis.
The recent work shows that an ERV known as MERVL switches on briefly during the earliest cleavage stages of mouse embryos, helping cells maintain the totipotent state — the rare condition in which a single cell can produce every tissue type, including the placenta. Without the carefully timed activation of these viral elements, embryos struggle to progress beyond the two-cell stage. As the team behind one of the studies noted in coverage by Nature, this points to viruses having been “domesticated” as essential developmental tools rather than passively coexisting with their hosts.
How the Discovery Was Made
Using single-cell sequencing combined with CRISPR-based interference, scientists were able to silence specific ERV sequences in early embryos and watch development falter. Conversely, when researchers reactivated viral elements in cultured stem cells, they could push those cells back toward a more primitive, totipotent-like state — an advance with profound implications for regenerative medicine. Similar findings have emerged in human embryonic stem cell models studied by groups affiliated with the European Molecular Biology Organization, where a different family of ERVs, HERVH, appears to maintain pluripotency in human cells.
What makes the findings particularly striking is the apparent convergence: independent viral invasions in different mammalian lineages have been co-opted for the same biological purpose. This suggests that early embryos may have repeatedly turned to viral DNA as a source of regulatory innovation, a phenomenon some researchers have begun calling “viral domestication.”
Why It Matters for Evolutionary Biology
The implications stretch well beyond developmental biology. If endogenous retroviruses have been routinely repurposed as switches controlling identity, timing, and gene expression in embryos, then the standard narrative — in which evolution proceeds primarily through point mutations in protein-coding genes — looks incomplete. Viral integration may instead be one of the major engines of evolutionary novelty, supplying ready-made regulatory modules that natural selection can fine-tune.
This view aligns with broader work on transposable elements and genome evolution, and it raises pointed questions about human disease. Aberrant reactivation of ERVs has been linked to autoimmune conditions, certain cancers, and neurological disorders. Understanding the rules that govern when viral DNA should and should not be active may unlock new therapeutic strategies.
What to Watch Next
Researchers are now racing to map the full catalogue of ERVs that play developmental roles across species, and to determine whether reactivating these sequences in adult cells could enable safer, more efficient stem-cell therapies. Clinical translation remains years away, but synthetic-biology groups are already exploring whether engineered ERV-like switches could be used to reprogram cells on demand. As the line between “host” and “virus” continues to blur, the field is likely to deliver more surprises about just how deeply our evolutionary history is written in borrowed code.
For more reporting on genomics, evolution, and the frontiers of life science, visit and bookmark science.wide-ranging.com for related coverage and in-depth features.
